Steven Cohen's MPLT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 426,261 shares of MapLight Therapeutics, Inc. (MPLT) worth $4.34 M, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in MPLT, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's MapLight Therapeutics (MPLT) Holding Value Over Time
Track share changes against reported price movement
Quarterly MapLight Therapeutics (MPLT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +426,261 | New Buy | 426,261 | $10.19 |
Steven Cohen's MapLight Therapeutics Investment FAQs
Steven Cohen first purchased MapLight Therapeutics, Inc. (MPLT) in Q3 2026, acquiring 426,261 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held MapLight Therapeutics, Inc. (MPLT) for 1 quarters since Q3 2026.
Steven Cohen's largest addition to MapLight Therapeutics, Inc. (MPLT) was in Q3 2026, adding 426,261 shares worth $4.34 M.
According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 426,261 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $4.34 M.
As of the Q3 2026 filing, MapLight Therapeutics, Inc. (MPLT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in MapLight Therapeutics, Inc. (MPLT) was 426,261 shares, as reported at the end of Q3 2026.